By Tre Critelli In September of 2000, the Food and Drug Administration (FDA) approved the marketing and use of mifepristone (brand name Mifeprex, but commonly known as RU-486) for the termination of early intrauterine pregnancy, which is defined as a pregnancy of 49 days or less counting from the last menstrual period. The FDA conditioned the distribution of…

Read More

By Tom Quiner I just got back from the Iowa Board of Medicine who heard various speakers express their concern about telemedicine abortions. If the Board decides that telemed abortions are unsafe, they could halt this practice in its tracks before it spreads nationwide through other Planned Parenthood clinics. One speaker, Charles Burke, produced 1960…

Read More

By Maggie DeWitte, Executive Director of Iowans for L.I.F.E. Have we gone too far? In this world of rapidly advancing medical technology, the need exists to frequently step back and look honestly at what the possible outcome of each new advancement might be. That certainly is the case for the telemedicine abortion scheme being tested…

Read More